Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$66.63 USD

66.63
12,908,298

-0.22 (-0.33%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $66.63 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

CVS Health (CVS) Ascends While Market Falls: Some Facts to Note

CVS Health (CVS) reachead $66.85 at the closing of the latest trading day, reflecting a +1.33% change compared to its last close.

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Moumi Mondal headshot

Assessing WBA Before Q4 Earnings: How Should You Play the Stock?

A challenging retail environment and pharmacy trends are expected to cloud Walgreens' performance in the fourth quarter of fiscal 2024.

Why the Market Dipped But CVS Health (CVS) Gained Today

CVS Health (CVS) reachead $62.92 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close.

Urmimala Biswas headshot

CVS Stock Hits 50-Day SMA on Split Rumors: How Should You Play?

The market speculates that following the FTC notice, several investors are pushing CVS Health to go for segment breakups.

David Bartosiak headshot

Is CVS Health Stock Finally a Value Buy?

Value traps are dangerous. Buying a stock just because it is down well off its highs does not always work out.

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

New Strong Sell Stocks for September 27th

ASO, AVD and CVS have been added to the Zacks Rank #24 (Strong Sell) List on September 27, 2024.

CVS Health (CVS) Ascends While Market Falls: Some Facts to Note

In the closing of the recent trading day, CVS Health (CVS) stood at $58.64, denoting a +0.96% change from the preceding trading day.

Urmimala Biswas headshot

WBA Stock Dips 5% Post Fed Rate Cut: Should You Sell Walgreens Boots?

WBA is currently facing challenges within its U.S. Retail Pharmacy segment due to an unfavorable consumer environment and adverse pharmacy industry trends.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

The latest trading day saw CVS Health (CVS) settling at $58.40, representing a -0.03% change from its previous close.

Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?

Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

CVS Health (CVS) Rises Higher Than Market: Key Facts

The latest trading day saw CVS Health (CVS) settling at $57.98, representing a +0.78% change from its previous close.

CVS Stock Gains From Its Birth Control Prescribing Service Launch

CVS Health announces that nearly 400 CVS Pharmacy locations in Massachusetts have started offering hormonal contraceptive prescribing services.

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Why Is CVS Health (CVS) Up 0.4% Since Last Earnings Report?

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Herbalife and Amazon

CVS Health, Walgreens Boots Alliance, Herbalife and Amazon are part of the Zacks Industry Outlook article.

Urmimala Biswas headshot

3 Stocks to Avoid From The Volatile Retail Pharmacy Industry

Zacks Retail-Pharmacies and Drug Stores industry players like CVS, WBA and HLF are likely to be affected by reimbursement challenges that are hurting the overall health of the industry.

Urmimala Biswas headshot

CVS Stock Tanks 27.5% Year to Date: Time to Buy the Dip?

While CVS Health has been grappling with pharmacy reimbursement pressure, a turnaround might be in the cards, given its several strategic initiatives.

Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Kaibalya Pravo Dey headshot

UnitedHealth (UNH) Rises 15% in 3 Months: Jump in or Wait out?

UnitedHealth's (UNH) expansion into targeted markets, strategic diversification and attractive dividends present significant growth opportunities.

Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

New Strong Sell Stocks for August 15th

ARCO, CNMD and CVS have been added to the Zacks Rank #5 (Strong Sell) List on August 15, 2024.

Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?

According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?